CARL
Income statement / Annual
Last year (2025), Carlsmed Inc's total revenue was $50.51 M,
an increase of 85.94% from the previous year.
In 2025, Carlsmed Inc's net income was -$30.22 M.
See Carlsmed Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
| Operating Revenue |
$50.51 M |
$27.17 M |
$13.78 M |
| Cost of Revenue |
$12.47 M
|
$7.12 M
|
$3.88 M
|
| Gross Profit |
$38.04 M
|
$20.05 M
|
$9.90 M
|
| Gross Profit Ratio |
0.75
|
0.74
|
0.72
|
| Research and Development Expenses |
$17.02 M
|
$14.30 M
|
$7.40 M
|
| General & Administrative Expenses |
$16.57 M
|
$8.39 M
|
$6.00 M
|
| Selling & Marketing Expenses |
$35.03 M
|
$21.47 M
|
$15.10 M
|
| Selling, General & Administrative Expenses |
$51.60 M
|
$29.87 M
|
$21.10 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$68.61 M
|
$44.17 M
|
$28.49 M
|
| Cost And Expenses |
$81.09 M
|
$51.29 M
|
$32.37 M
|
| Interest Income |
$2.70 M
|
$1.33 M
|
$334.00 K
|
| Interest Expense |
-$1.43 M
|
$1.32 M
|
$641.00 K
|
| Depreciation & Amortization |
$0.00
|
$145.00 K
|
$136.00 K
|
| EBITDA |
-$30.57 M |
-$22.79 M |
-$18.12 M |
| EBITDA Ratio |
-0.61
|
-0.84
|
-1.32
|
| Operating Income Ratio |
-0.61
|
-0.89
|
-1.35
|
| Total Other Income/Expenses Net |
$356.00 K
|
-$135.00 K
|
-$307.00 K
|
| Income Before Tax |
-$30.22 M
|
-$24.26 M
|
-$18.90 M
|
| Income Before Tax Ratio |
-0.6
|
-0.89
|
-1.37
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$30.22 M
|
-$24.26 M
|
-$18.90 M
|
| Net Income Ratio |
-0.6
|
-0.89
|
-1.37
|
| EPS |
-2.12 |
-1.5 |
-4.25 |
| EPS Diluted |
-2.12 |
-1.5 |
-4.25 |
| Weighted Average Shares Out |
$14.22 M
|
$16.56 M
|
$4.45 M
|
| Weighted Average Shares Out Diluted |
$14.22 M
|
$16.56 M
|
$4.45 M
|
| Link |
|
|
|
